Drug class in one race

Kappa-opioid receptor (agonist, peripherally restricted) drugs for Chronic Kidney Disease

2 tracked Kappa-opioid receptor (agonist, peripherally restricted) drugs in the Chronic Kidney Disease race. The class explanation lives on the Kappa-opioid receptor (agonist, peripherally restricted) page; the full indication pipeline across every mechanism is on the Chronic Kidney Disease page.

Head-to-head evidence: Anrikefon (HSK21542) vs Difelikefalin

← all Kappa-opioid receptor (agonist, peripherally restricted) drugs